Insider Trading: HALOZYME THERAPEUTICS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by
insiders of HALOZYME THERAPEUTICS INC since year 2005 are given in the first table.
The second table lists detailed insider transactions reported by HALOZYME THERAPEUTICS INC since 2005.
The reporting company's ticker symbol is HTI .
The reporting company's CIK number is 1159036 .
The total value of stock buying during this period is $67,316,628.
The total value of stock sales is $14,087,537.
The total value of stock exercises is $1,749,025.
Figure 1. Monthly insider transaction values at HALOZYME THERAPEUTICS INC (HTI) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
06
07
08
09
10
11
12
01 2007
02
03
04
05
06
07
08
09
10
11
12
01 2008
02
03
04
05
Figure 2. Average prices of insider buys, sales, and option exercises at HALOZYME THERAPEUTICS INC (HTI) in the past 24 months. See table 2 for insider transaction details.
06
07
08
09
10
11
12
01 2007
02
03
04
05
06
07
08
09
10
11
12
01 2008
02
03
04
05
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for HALOZYME THERAPEUTICS INC (HTI ).
Trading Period
Insider Buying
Insider Sales
Option Exercises
2008-03 4,566,245 26,074,201 480,000 2,908,800 869,902 364,857 2007-12 0 0 9,137 63,959 52,496 22,572 2007-11 0 0 51,500 409,304 85,317 35,885 2007-10 0 0 100,000 896,579 83,191 35,294 2007-09 470,000 4,092,942 87,471 779,269 109,105 45,913 2007-08 0 0 123,300 1,024,108 204,381 86,878 2007-07 0 0 75,000 702,095 117,940 48,714 2007-06 0 0 173,601 1,702,041 216,152 112,214 2007-05 3,500,000 32,095,000 189,100 1,969,071 47,500 133,749 2007-04 0 0 200,000 1,772,563 125,000 512,495 2007-03 80,280 638,829 223,096 1,859,748 180,833 350,454 2006-12 481,200 2,543,540 0 0 0 0 2006-09 282,500 709,776 0 0 0 0 2006-08 421,600 1,054,585 0 0 0 0 2005-08 23,000 38,855 0 0 0 0 2005-05 35,000 68,900 0 0 0 0
Table 2. Detailed insider stock purchases, sales, and option exercises
for HALOZYME THERAPEUTICS INC (HTI )
Trade Date
Insider Name
Trade Type
Shares
Price ($)
Value ($)
2008-03-20 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 230,000 6.06 1,393,800 2008-03-20 Lim Jonathan E (President, CEO) Sale 250,000 6.06 1,515,000 2008-03-20 Little Robert J (VP, Chief Commercial Officer) Purchase 9,000 5.98 53,775 2008-03-20 Kirk Randal J Purchase 1,264,657 6.09 7,701,761 2008-03-19 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 639,902 .43 275,157 2008-03-19 Lim Jonathan E (President, CEO) Option Exercise 230,000 .39 89,700 2008-03-19 Kirk Randal J Purchase 1,773,300 5.80 10,285,140 2008-03-18 Ramsay David A (Secretary, CFO) Purchase 10,000 4.55 45,500 2008-03-18 Kirk Randal J Purchase 415,092 4.57 1,896,970 2007-12-20 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 9,137 7.00 63,959 2007-12-20 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 9,736 .43 4,186 2007-12-11 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 42,760 .43 18,386 2007-11-30 Lim Jonathan E (President, CEO) Sale 20,000 8.22 164,400 2007-11-30 Lim Jonathan E (President, CEO) Option Exercise 20,000 .39 7,800 2007-11-21 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 10,000 7.65 76,505 2007-11-21 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 10,603 .43 4,559 2007-11-20 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 11,700 7.93 91,837 2007-11-20 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 12,374 .43 5,320 2007-11-09 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 42,340 .43 18,206 2007-10-31 Lim Jonathan E (President, CEO) Sale 25,000 9.07 226,638 2007-10-31 Lim Jonathan E (President, CEO) Option Exercise 25,000 .39 9,750 2007-10-25 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 15,000 9.05 135,728 2007-10-25 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 15,754 .43 6,774 2007-10-24 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 15,000 9.00 135,035 2007-10-24 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 15,747 .43 6,771 2007-10-16 Lim Jonathan E (President, CEO) Option Exercise 26,690 .45 11,999 2007-10-16 Patton John Stuart (Director) Sale 15,000 9.02 135,300 2007-10-09 Patton John Stuart (Director) Sale 15,000 8.70 130,453 2007-10-02 Patton John Stuart (Director) Sale 15,000 8.90 133,425 2007-09-28 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 52,602 .43 22,618 2007-09-28 Lim Jonathan E (President, CEO) Sale 25,000 8.77 219,310 2007-09-28 Lim Jonathan E (President, CEO) Option Exercise 25,000 .39 9,750 2007-09-27 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 15,000 8.96 134,335 2007-09-27 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 15,757 .43 6,775 2007-09-26 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 15,000 9.07 136,089 2007-09-26 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 15,746 .43 6,770 2007-09-25 Patton John Stuart (Director) Sale 15,000 8.94 134,172 2007-09-19 Kirk Randal J Purchase 23,085 9.00 207,765 2007-09-18 Patton John Stuart (Director) Sale 17,471 8.89 155,363 2007-09-18 Kirk Randal J Purchase 15,489 8.87 137,387 2007-09-17 Kirk Randal J Purchase 238,020 8.66 2,061,253 2007-09-14 Kirk Randal J Purchase 127,693 8.71 1,112,206 2007-09-13 Kirk Randal J Purchase 65,713 8.74 574,331 2007-08-31 Lim Jonathan E (President, CEO) Sale 25,000 8.68 217,071 2007-08-31 Lim Jonathan E (President, CEO) Option Exercise 25,000 .39 9,750 2007-08-30 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 15,000 8.45 126,821 2007-08-30 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 15,815 .43 6,800 2007-08-29 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 15,000 8.30 124,534 2007-08-29 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 15,801 .43 6,794 2007-08-06 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 52,767 .43 22,689 2007-08-02 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 7,400 7.95 58,818 2007-08-02 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 31,632 .43 13,600 2007-08-01 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 30,000 8.08 242,288 2007-08-01 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 31,700 .43 13,630 2007-07-31 Lim Jonathan E (President, CEO) Sale 20,000 8.24 164,706 2007-07-31 Lim Jonathan E (President, CEO) Option Exercise 20,000 .39 7,800 2007-07-26 Ramsay David A (Secretary, CFO) Option Exercise 30,000 .39 11,700 2007-07-16 Ramsay David A (Secretary, CFO) Sale 10,000 9.89 98,887 2007-07-10 Patton John Stuart (Director) Sale 20,000 9.78 195,573 2007-07-09 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 41,812 .43 17,979 2007-07-06 Frost Gregory Ian (VP & Chief Scientific Ofcr) Sale 25,000 9.72 242,929 2007-07-06 Frost Gregory Ian (VP & Chief Scientific Ofcr) Option Exercise 26,128 .43 11,235 2007-06-29 Lim Jonathan E (President, CEO) Sale 25,000 9.48 236,211 2007-06-29 Lim Jonathan E (President, CEO) Option Exercise 25,000 .39 9,750 2007-06-26 Patton John Stuart (Director) Sale 20,000 8.83 176,134 2007-06-25 Lim Jonathan E (President, CEO) Option Exercise 96,313 .39 37,562 2007-06-19 Patton John Stuart (Director) Sale 20,000 10.28 205,616 2007-06-15 Thornton Steven T (Director) Sale 10,000 10.02 100,246 2007-06-15 Thornton Steven T (Director) Option Exercise 10,000 2.80 28,000 2007-06-14 Ramsay David A (Secretary, CFO) Sale 10,000 10.12 101,248 2007-06-12 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 43,137 .44 18,971 2007-06-12 Patton John Stuart (Director) Sale 20,000 10.09 201,863 2007-06-07 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 20,000 10.43 208,652 2007-06-07 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 20,853 .43 8,966 2007-06-06 Frost Gregory Ian (VP and Chief Scientific Off.) Sale 20,000 10.60 212,022 2007-06-06 Frost Gregory Ian (VP and Chief Scientific Off.) Option Exercise 20,849 .43 8,965 2007-05-31 Lim Jonathan E (President, CEO) Sale 25,000 10.48 260,336 2007-05-31 Lim Jonathan E (President, CEO) Option Exercise 12,500 .39 4,875 2007-05-30 Kirk Randal J Purchase 3,500,000 9.17 32,095,000 2007-05-29 Patton John Stuart (Director) Sale 20,000 10.31 206,107 2007-05-25 Kelley Kenneth J (Director) Sale 22,500 10.27 231,065 2007-05-25 Kelley Kenneth J (Director) Option Exercise 22,500 3.45 77,625 2007-05-23 Patton John Stuart (Director) Sale 15,000 10.52 157,800 2007-05-22 Patton John Stuart (Director) Sale 20,000 10.53 210,557 2007-05-21 Thornton Steven T (Director) Sale 30,000 10.50 315,000 2007-05-18 Kelley Kenneth J (Director) Sale 15,000 10.56 158,329 2007-05-14 Ramsay David A (Secretary, CFO) Sale 10,000 10.19 101,900 2007-05-07 Kelley Kenneth J (Director) Sale 12,500 10.42 130,240 2007-05-07 Kelley Kenneth J (Director) Option Exercise 12,500 4.10 51,249 2007-04-30 Kelley Kenneth J (Director) Sale 25,000 10.32 258,093 2007-04-30 Kelley Kenneth J (Director) Option Exercise 25,000 4.10 102,499 2007-04-23 Kelley Kenneth J (Director) Sale 25,000 8.89 222,305 2007-04-23 Kelley Kenneth J (Director) Option Exercise 25,000 4.10 102,499 2007-04-18 Patton John Stuart (Director) Sale 25,000 9.13 228,369 2007-04-16 Kelley Kenneth J (Director) Sale 25,000 9.07 226,714 2007-04-16 Kelley Kenneth J (Director) Option Exercise 25,000 4.10 102,499 2007-04-11 Patton John Stuart (Director) Sale 25,000 8.61 215,312 2007-04-09 Kelley Kenneth J (Director) Sale 25,000 8.46 211,625 2007-04-09 Kelley Kenneth J (Director) Option Exercise 25,000 4.10 102,499 2007-04-04 Patton John Stuart (Director) Sale 25,000 8.35 208,750 2007-04-02 Kelley Kenneth J (Director) Sale 25,000 8.06 201,395 2007-04-02 Kelley Kenneth J (Director) Option Exercise 25,000 4.10 102,499 2007-03-28 Patton John Stuart (Director) Sale 25,000 8.40 209,960 2007-03-27 Kelley Kenneth J (Director) Sale 8,738 8.35 72,694 2007-03-26 Kelley Kenneth J (Director) Sale 16,262 8.43 137,096 2007-03-26 Kelley Kenneth J (Director) Option Exercise 25,000 2.05 51,249 2007-03-22 Thornton Steven T (Director) Sale 10,000 8.51 85,107 2007-03-22 Thornton Steven T (Director) Option Exercise 10,000 1.75 17,500 2007-03-22 Yocum Richard C (VP Clinical Development) Sale 29,858 8.51 254,091 2007-03-21 Yocum Richard C (VP Clinical Development) Option Exercise 95,833 1.87 179,207 2007-03-21 Patton John Stuart (Director) Sale 25,000 8.61 215,282 2007-03-19 Kelley Kenneth J (Director) Sale 25,000 8.71 217,703 2007-03-19 Kelley Kenneth J (Director) Option Exercise 25,000 2.05 51,249 2007-03-19 Little Robert J (VP, Chief Commercial Officer) Purchase 4,000 8.63 34,533 2007-03-15 Patton John Stuart (Director) Sale 8,600 8.00 68,800 2007-03-15 Engler Robert (Director) Sale 25,000 8.04 201,083 2007-03-14 Kelley Kenneth J (Director) Sale 25,000 7.92 197,906 2007-03-14 Kelley Kenneth J (Director) Option Exercise 25,000 2.05 51,249 2007-03-14 Patton John Stuart (Director) Sale 16,400 8.02 131,528 2007-03-14 Kirk Randal J Purchase 30,200 7.91 238,882 2007-03-13 Kirk Randal J Purchase 46,080 7.93 365,414 2006-12-11 Kirk Randal J Purchase 80,000 6.16 492,800 2006-12-07 Kirk Randal J Purchase 336,200 5.55 1,865,910 2006-12-05 Kirk Randal J Purchase 53,500 2.84 151,940 2006-12-04 Kirk Randal J Purchase 11,500 2.86 32,890 2006-09-15 Kirk Randal J Purchase 102,500 2.50 256,250 2006-09-14 Kirk Randal J Purchase 20,000 2.50 50,000 2006-09-13 Kirk Randal J Purchase 74,000 2.50 185,000 2006-09-12 Kirk Randal J Purchase 20,000 2.58 51,600 2006-09-11 Kirk Randal J Purchase 3,200 2.54 8,128 2006-09-08 Kirk Randal J Purchase 30,500 2.52 76,860 2006-09-07 Kirk Randal J Purchase 15,000 2.51 37,650 2006-09-06 Kirk Randal J Purchase 17,300 2.56 44,288 2006-08-29 Kirk Randal J Purchase 23,000 2.60 59,800 2006-08-28 Kirk Randal J Purchase 60,000 2.56 153,600 2006-08-25 Kirk Randal J Purchase 110,900 2.50 277,250 2006-08-24 Kirk Randal J Purchase 93,300 2.50 233,250 2006-08-23 Kirk Randal J Purchase 6,700 2.49 16,683 2006-08-22 Kirk Randal J Purchase 17,600 2.46 43,296 2006-08-21 Kirk Randal J Purchase 12,500 2.46 30,750 2006-08-18 Kirk Randal J Purchase 3,500 2.42 8,470 2006-08-17 Kirk Randal J Purchase 94,100 2.46 231,486 2005-08-24 Ramsay David A (Secretary, CFO) Purchase 10,000 1.70 17,000 2005-08-23 Kennard Don A (Vice President, Regu) Purchase 3,000 1.66 4,980 2005-08-23 Frost Gregory Ian (VP and Chief Scienti) Purchase 5,000 1.69 8,450 2005-08-23 Ramsay David A (Secretary, CFO) Purchase 5,000 1.68 8,425 2005-05-27 Ramsay David A (Secretary, CFO) Purchase 10,000 1.99 19,900 2005-05-24 Engler Robert (Director) Purchase 25,000 1.96 49,000
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of HALOZYME THERAPEUTICS INC (symbol HTI ,
CIK number 1159036 ) see
the Securities and Exchange Commission (SEC) website.
